Formulation approaches to pediatric oral drug delivery: benefits and limitations of current platforms

Bibliography

• European Medicines Agency. Guideline on pharmaceutical development of medicines for paediatric use. (EMA/CHMP/QWP/805880/2012). Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2013/07/WC500147002.pdf [Last accessed 06 July 2015]
   Google Scholar
• Richey RH, Shah UU, Peak M, et al. Manipulation of drugs to achieve the required dose is intrinsic to paediatric practice but is not supported by guidelines or evidence. BMC Pediatr 2013;13(81):1–8
   PubMed Web of Science ®Google Scholar
• Batchelor HK, Marriott JF. Formulations for children: problems and solutions. Br J Clin Pharmacol 2013;79(3):1–31
   Google Scholar
• Salunke S, Brandys B, Giacoia G, et al. The STEP (Safety and Toxicity of Excipients for Paediatrics) database: part 2 - the pilot version. Int J Pharm 2013;457(1):310–22
   PubMed Web of Science ®Google Scholar
• Ivanovska V, Rademaker CM, van Dijk L, et al. Pediatric drug formulations: a review of challenges and progress. Pediatrics 2014;134(2):361–72
   PubMed Web of Science ®Google Scholar
• Kozarewicz P. Regulatory perspectives on acceptability testing of dosage forms in children. Int J Pharm 2014;469(2):245–8
   PubMed Web of Science ®Google Scholar
• Wening K, Breitkreutz J. Oral drug delivery in personalized medicine: unmet needs and novel approaches. Int J Pharm 2011;404(1-2):1–9
   PubMed Web of Science ®Google Scholar
• Sosnik A, Seremeta KP, Imperiale JC, et al. Novel formulation and drug delivery strategies for the treatment of pediatric poverty-related diseases. Expert Opin Drug Delivery 2012;9:303–23
   PubMed Web of Science ®Google Scholar
• Sam T, Ernest TB, Walsh J, et al. A benefit/risk approach towards selecting appropriate pharmaceutical dosage forms - an application for paediatric dosage form selection. Int J Pharm 2012;435(2):115–23
   PubMed Web of Science ®Google Scholar
• World Health Organisation. Development of paediatric medicines: points to consider in formulation. 2012. Available from: http://www.who.int/medicines/areas/quality_safety/quality_assurance/Rev3-PaediatricMedicinesDevelopment_QAS08-257Rev3_17082011.pdf [Last accessed 19 January 2015]
   Google Scholar
• Turner MA, Catapano M, Hirschfeld S, et al. Paediatric drug development: the impact of evolving regulations. Adv Drug Delivery Rev 2014;73:2–13
   PubMed Web of Science ®Google Scholar
• Cuña M, Vila Jato JL, Torres D. Controlled-release liquid suspensions based on ion-exchange particles entrapped within acrylic microcapsules. Int J Pharm 2000;199(2):151–8
   PubMed Web of Science ®Google Scholar
• Haznar-Garbacz D, Garbacz G, Eisenacher F, et al. An oral-controlled release drug delivery system for liquid and semisolid drug formulations. AAPS PharmSciTech 2011;12(4):1183–5
   PubMed Web of Science ®Google Scholar
• Mishra B, Sahoo BL, Mishra M, et al. Design of a controlled release liquid formulation of lamotrigine. DARU J Pharma Sci 2011;19(2):126–37
   Web of Science ®Google Scholar
• Buck ML, Health C. Alternative forms of oral drug delivery for pediatric patients. Pediatr Pharmacother 2013;19:3
   Google Scholar
• Childress A, Sallee FR. The use of methylphenidate hydrochloride extended-release oral suspension for the treatment of ADHD. Expert Rev Neurother 2013;13(9):979–88
   PubMed Web of Science ®Google Scholar
• Amrol D. Single-dose azithromycin microsphere formulation: a novel delivery system for antibiotics. Int J Nanomed 2007;2(1):9–12
   PubMed Web of Science ®Google Scholar
• Kytariolos J, Charkoftaki G, Smith JR, et al. Stability and physicochemical characterization of novel milk-based oral formulations. Int J Pharm 2013;444(1-2):128–38
   PubMed Web of Science ®Google Scholar
• Charkoftaki G, Kytariolos J, Macheras P. Novel milk-based oral formulations: proof of concept. Int J Pharm 2010;390(2):150–9
   PubMed Web of Science ®Google Scholar
• JustMilk. Safely delivering drugs and nutrients to breastfeeding infants. Available from: http://www.justmilk.org [Last accessed 04 June 2015]
   Google Scholar
• Gerrard SE, Baniecki ML, Sokal DC, et al. A nipple shield delivery system for oral drug delivery to breastfeeding infants: microbicide delivery to inactivate HIV. Int J Pharm 2012;434(1-2):224–34
   PubMed Web of Science ®Google Scholar
• Monteagudo E, Langenheim M, Salerno C, et al. Pharmaceutical optimization of lipid-based dosage forms for the improvement of taste-masking, chemical stability and solubilizing capacity of phenobarbital. Drug Develop Indust Pharm 2014;40(6):783–92
   PubMed Web of Science ®Google Scholar
• Tan A, Rao S, Prestidge CA. Transforming lipid-based oral drug delivery systems into solid dosage forms: an overview of solid carriers, physicochemical properties, and biopharmaceutical performance. Pharma Res 2013;30(12):2993–3017
   Web of Science ®Google Scholar
• Kraus DM, Stohlmeyer LA, Hannon PR, et al. Effectiveness and infant acceptance of the Rx medibottle versus the oral syringe. Pharmacotherapy 2001;21(4):416–23
   PubMed Web of Science ®Google Scholar
• Walsh J, Bickmann D, Breitkreutz J, et al. Delivery devices for the administration of paediatric formulations: overview of current practice, challenges and recent developments. Int J Pharm 2011;415(1-2):221–31
   PubMed Web of Science ®Google Scholar
• Richter F. Sipping devices: new technologies. Available from: http://www.raumedic.com/fileadmin/user_upload/PDF/drug-delivery-sipping-device.pdf [Last accessed 19 January 2015]
   Google Scholar
• Meltzer EO, Welch MJ, Ostrom NK. Pill swallowing ability and training in children 6 to 11 years of age. Clin Pediatr 2006;45(8):725–33
   PubMed Web of Science ®Google Scholar
• Schiele JT, Schneider H, Quinzler R, et al. Two techniques to make swallowing pills easier. Ann Family Med 2014;12(6):550–2
   PubMed Web of Science ®Google Scholar
• Margiocco ML, Warren J, Borgarelli M, et al. Analysis of weight uniformity, content uniformity and 30-day stability in halves and quarters of routinely prescribed cardiovascular medications. J Veter Cardiol 2009;11(1):31–9
   PubMedGoogle Scholar
• van Riet-Nales DA, Doeve ME, Nicia AE, et al. The accuracy, precision and sustainability of different techniques for tablet subdivision: breaking by hand and the use of tablet splitters or a kitchen knife. Int J Pharm 2014;466(1-2):44–51
   PubMed Web of Science ®Google Scholar
• Kayitare E, Vervaet C, Ntawukulilyayo JD, et al. Development of fixed dose combination tablets containing zidovudine and lamivudine for paediatric applications. Int J Pharm 2009;370(1-2):41–6
   PubMed Web of Science ®Google Scholar
• Solomon L, Kaplan AS. Method of administering a partial dose using segmented pharmaceutical tablet. US0031494; 2007
   Google Scholar
• Laukamp EJ, Thommes M, Breitkreutz J. Hot-melt extruded drug-loaded rods: Evaluation of the mechanical properties for individual dosing via the Solid Dosage Pen. Int J Pharm 2014;475(1-2):344–50
   PubMed Web of Science ®Google Scholar
• Wening K, Breitkreutz J. Novel delivery device for monolithical solid oral dosage forms for personalized medicine. Int J Pharm 2010;395(1-2):174–81
   PubMed Web of Science ®Google Scholar
• Thomson SA, Tuleu C, Wong IC, et al. Minitablets: new modality to deliver medicines to preschool-aged children. Pediatrics 2009;123(2):235–8
   PubMed Web of Science ®Google Scholar
• Spomer N, Klingmann V, Stoltenberg I, et al. Acceptance of uncoated mini-tablets in young children: results from a prospective exploratory cross-over study. Arch Dis Childhood 2012;97(3):283–6
   PubMed Web of Science ®Google Scholar
• Zedler BK, Kakad P, Colilla S, et al. Does packaging with a calendar feature improve adherence to self-administered medication for long-term use? A systematic review. Clin Therap 2011;33(1):62–73
   PubMed Web of Science ®Google Scholar
• Engelen L, Van Der Bilt A, Schipper M, et al. Oral Size Perception of Particles Effect of Size, Type, Viscosity and Method. J Text Studies 2005;36(4):373–86
   Web of Science ®Google Scholar
• Imai E, Hatae K, Shimada A. Oral perception of grittiness: Effect of particle size and concentration of the dispersed particles and the dispersion medium. J Text Studies 1995;26(5):561–76
   Web of Science ®Google Scholar
• Food and Drugs Administration. Guidance for Industry: Size of beads in drug products labeled for sprinkle 2012. Available from: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM240243.pdf [Last accessed 19 January 2015]
   Google Scholar
• Thompson CA, Lombardi DP, Sjostedt P, et al. Industry survey on current practices in the assessment of palatability and swallowability in the development of pediatric oral dosage forms. Therap Innov Regulat Sci 2013;47(5):542–9
   Google Scholar
• Kluk A, Sznitowska M. Application properties of oral gels as media for administration of minitablets and pellets to paediatric patients. Int J Pharm 2014;460(1-2):228–33
   PubMed Web of Science ®Google Scholar
• World Health Organisation. WHO model formulary for children 2010. Available from: www.who.int/selection_medicines/list/WMFc_2010.pdf [Last accessed 12 November 2014]
   Google Scholar
• MacDonald A, Lilburn M, Davies P, et al. ‘Ready to drink’ protein substitute is easier is for people with phenylketonuria. J Inher Metab Dis 2006;29(4):526–31
   PubMed Web of Science ®Google Scholar
• Den Uyl D, Geusens PP, Van Berkum FNR, et al. Patient preference and acceptability of calcium plus vitamin D3 supplementation: A randomised, open, cross-over trial. Clin Rheumatol 2010;29(5):465–72
   PubMed Web of Science ®Google Scholar
• Batchelor HK, Fotaki N, Klein S. Paediatric oral biopharmaceutics: key considerations and current challenges. Adv Drug Delivery Rev 2014;73:102–26
   PubMed Web of Science ®Google Scholar
• Albertini B, Di Sabatino M, Melegari C, et al. Formulating SLMs as oral pulsatile system for potential delivery of melatonin to pediatric population. Int J Pharm 2014;469(1):67–79
   PubMed Web of Science ®Google Scholar
• Desai D, Wang J, Wen H, et al. Formulation design, challenges, and development considerations for fixed dose combination (FDC) of oral solid dosage forms. Pharma Develop Technol 2013;18(6):1265–76
   PubMed Web of Science ®Google Scholar
• Abdul S, Chandewar AV, Jaiswal SB. A flexible technology for modified-release drugs: multiple-unit pellet system (MUPS). J Cont Rel 2010;147(1):2–16
   PubMed Web of Science ®Google Scholar
• Varum FJ, Merchant HA, Basit AW. Oral modified-release formulations in motion: the relationship between gastrointestinal transit and drug absorption. Int J Pharm 2010;395(1-2):26–36
   PubMed Web of Science ®Google Scholar
• Figueroa CE, Bose S. Spray granulation: importance of process parameters on in vitro and in vivo behavior of dried nanosuspensions. Eur J Pharma Biopharma 2013;85:1046–55
   PubMed Web of Science ®Google Scholar
• Corrigan DO, Healy AM, Corrigan OI. Preparation and release of salbutamol from chitosan and chitosan co-spray dried compacts and multiparticulates. Eur J Pharma Biopharma 2006;62(3):295–305
   PubMed Web of Science ®Google Scholar
• Vervaeck A, Monteyne T, Saerens L, et al. Prilling as manufacturing technique for multiparticulate lipid/PEG fixed-dose combinations. Eur J Pharma Biopharma 2014;88(2):472–82
   PubMed Web of Science ®Google Scholar
• Fitzpatrick J, Sivadas N, Nolan F, et al. Novel encapsulation technology can address your formulation challenges 2013. Available from: http://www.freundpharmatec.com/uploads/Ethicap-Gel-Whitepaper.pdf [Last accessed 19 January 2015]
   Google Scholar
• Bouffard J, Dumont H, Bertrand F, et al. Optimization and scale-up of a fluid bed tangential spray rotogranulation process. Int J Pharm 2007;335(1-2):54–62
   PubMed Web of Science ®Google Scholar
• Tissen C, Woertz K, Breitkreutz J, et al. Development of mini-tablets with 1mm and 2mm diameter. Int J Pharm 2011;416(1):164–70
   PubMed Web of Science ®Google Scholar
• Aleksovski A, Dreu R, Gašperlin M, Planinšek O. Mini-tablets: a contemporary system for oral drug delivery in targeted patient groups. Expert Opin Drug Deliv 2015;12:65–84
   PubMed Web of Science ®Google Scholar
• Capsugel. Coni-Snap® sprinkle capsules. Available from: http://capsugel.com/media/library/coni-snap_sprinkle-capsules.pdf [Last accessed 19 January 2015]
   Google Scholar
• Olenak JL. OTC product zicam cold and flu medicated spoons. J Am Pharma Assoc 2006;46(6):52–3
   Web of Science ®Google Scholar
• Liang AC, Chen LH. Fast-dissolving intraoral drug delivery systems. Expert Opin Ther Patents 2001;11(6):981–6
   Web of Science ®Google Scholar
• Stoltenberg I, Breitkreutz J. Orally disintegrating mini-tablets (ODMTs)–a novel solid oral dosage form for paediatric use. Eur J Pharma Biopharma 2011;78(3):462–9
   PubMed Web of Science ®Google Scholar
• Patel VF, Liu F, Brown MB. Advances in oral transmucosal drug delivery. J Cont Rel 2011;153(2):106–16
   PubMed Web of Science ®Google Scholar
• Walsh J, Cram A, Woertz K, et al. Playing hide and seek with poorly tasting paediatric medicines: do not forget the excipients. Adv Drug Delivery Rev 2014;73:14–33
   PubMed Web of Science ®Google Scholar
• Stange U, Fuhrling C, Gieseler H. Taste masking of naproxen sodium granules by fluid-bed coating. Pharma Develop Technol 2014;19(2):137–47
   PubMed Web of Science ®Google Scholar
• Venkatesh GM, Stevens PJ, Lai JW. Development of orally disintegrating tablets comprising controlled-release multiparticulate beads. Drug Develop Indust Pharma 2012;38(12):1428–40
   PubMed Web of Science ®Google Scholar
• Shukla D, Mouth Dissolving Tablets I. An overview of formulation technology. Scie Pharma 2009;77(2):309–26
   Google Scholar
• Al-khattawi A, Mohammed AR. Compressed orally disintegrating tablets excipients evolution and formulation strategies. Expert Opin Drug Delivery 2013;10(5):651–63
   PubMed Web of Science ®Google Scholar
• Douroumis D. Orally disintegrating dosage forms and taste-masking technologies. Expert Opin Drug Delivery 2011;8(5):665–75
   PubMed Web of Science ®Google Scholar
• Badgujar BP, Mundada AS. The technologies used for developing orally disintegrating tablets: a review. Acta Pharma 2011;61(2):117–39
   PubMed Web of Science ®Google Scholar
• Pharmaceutical & Medical Packaging news. New routes in oral dosing 2011. Available from: http://www.pmpnews.com/passport/oraldosing.html [Last accessed 19 January 2015]
   Google Scholar
• Badgujar BP, Mundada AS. The technologies used for developing orally disintegrating tablets: a review. Acta Pharma 2011;61(2):117–39
   PubMed Web of Science ®Google Scholar
• Aprecia Pharmaceuticals. ZipDose® Technology 2014. Available from: https://www.aprecia.com/zipdose-platform/zipdose-technology.php [Last accessed 19 January 2015]
   Google Scholar
• Food and Drugs Administration. PREVACID medication guide. Available from: http://www.fda.gov/downloads/Drugs/DrugSafety/UCM322354.pdf [Last accessed 19 January 2015]
   Google Scholar
• Hoffmann EM, Breitenbach A. Advances in orodispersible films for drug delivery. Expert Opin Drug Delivery 2011;8(3):299–316
   PubMed Web of Science ®Google Scholar
• Mura P, Mennini N, Kosalec I, et al. Amidated pectin-based wafers for econazole buccal delivery: Formulation optimization and antimicrobial efficacy estimation. Carbohydr Polym 2015;121:231–40
   PubMed Web of Science ®Google Scholar
• Maniruzzaman M, Boateng JS, Snowden MJ, et al. A review of hot-melt extrusion: process technology to pharmaceutical products. ISRN Pharm 2012;2012:436763
   PubMedGoogle Scholar
• Yu DG, Shen XX, Branford-White C, et al. Oral fast-dissolving drug delivery membranes prepared from electrospun polyvinylpyrrolidone ultrafine fibers. Nanotechnology 2009;20(5):1–9
   Web of Science ®Google Scholar
• Buanz AB, Saunders MH, Basit AW, et al. Preparation of personalized-dose salbutamol sulphate oral films with thermal ink-jet printing. Pharm Res 2011;28(10):2386–92
   PubMed Web of Science ®Google Scholar
• Nagaraju T, Gowthami R, Rajashekar M, et al. Comprehensive review on oral disintegrating films. Curr Drug Delivery 2013;10(1):96–108
   PubMed Web of Science ®Google Scholar
• Market Wired. Paladin submits patent application for thinsol, a novel oral ingestible film composition delivery system 2007. Available from: http://www.marketwired.com/press-release/paladin-submits-patent-application-thinsol-novel-oral-ingestible-film-composition-tsx-plb-789353.htm [Last accessed 19 January 2015]
   Google Scholar
• Allen JD, Cobb ME, Hillman RS, et al. Integrated drug dosage form and metering system. US4712460; 1987
   Google Scholar
• Food and Drugs Administration. ZUPLENZ Oral Soluble Film prescribing information 2013. Available from: http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022524s002lbl.pdf [Last accessed 19 January 2015]
   Google Scholar
• Mishra B, Sharma G, Shukla D. Investigation of organoleptic characteristics in the development of soft chews of calcium carbonate as mineral supplement. Yakugaku Zasshi 2009;129(12):1537–44
   PubMed Web of Science ®Google Scholar
• Michele TM, Knorr B, Vadas EB, et al. Safety of chewable tablets for children. J Asthma 2002;39(5):391–403
   PubMed Web of Science ®Google Scholar
• European Medicines Agency. Reflection paper Formulations of choice for the paediatric population. (EMEA/CHMP/PEG/194810/2005). Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003782.pdf [Last accessed 06 July 2015]
   Google Scholar
• Paulsen NE, Johnson R, Coffee M. Process for manufacturing chewable dosage forms for drug delivery and products thereof. US 8114455; 2012
   Google Scholar
• Hassan EM, Kindt WW, Roger E. Chewable soft capsule. US08765174; 2014
   Google Scholar
• Ko C, Ko JJ, Ko Y, et al. Chewable softgel capsule, useful for encasing orally ingestible articles such as medicines and nutraceuticals, comprises an outer shell composition comprising gelatin, plasticizer, starch and an anti-tacking and softening agent. US092548; 2010
   Google Scholar
• Jójárt I, Kelemen A, Kása P, et al. Tracking of the post-compressional behaviour of chewing gum tablets. Composites Part B: Engineering 2013;49:1–5
   Web of Science ®Google Scholar
• Hyrup B, Andersen C, Andreasen LV, et al. The MediChew technology platform. Expert Opin Drug Delivery 2005;2(5):927–33
   PubMedGoogle Scholar
• Winzenburg G. More than 5 years of european paediatric regulation: statistics and industrial experience. Int J Pharm 2014;469(2):260–2
   PubMed Web of Science ®Google Scholar
• Van Riet-Nales DA, Schobben AF, Egberts TC, Rademaker CM. Effects of the pharmaceutical technologic aspects of oral pediatric drugs on patient-related outcomes: a systematic literature review. Clin Ther 2010;32(5):924–38
   PubMed Web of Science ®Google Scholar
• Liu F, Ranmal S, Batchelor HK, et al. Patient-centred pharmaceutical design to improve acceptability of medicines: similarities and differences in paediatric and geriatric populations. Drugs 2014;74(16):1871–89
   PubMed Web of Science ®Google Scholar
• Nakamura H, Ishikawa Y. How do Japanese children take their medicines, and what are pharmacists and paediatricians doing about it? Int J Pharm 2014;469(2):249–50
   PubMed Web of Science ®Google Scholar